MRx-4DP0004
MRx-4DP0004-I-001
Phase 1 small_molecule terminated
Quick answer
MRx-4DP0004 for Asthma is a Phase 1 program (small_molecule) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Asthma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated